EULAR 2026… EULAR 2026 Highlights – Rare & Autoinflammatory Diseases 22 Jul 202624 Jul 2026 Diagnostic yield and clinical impact of multigene autoinflammatory panels in adult routine care (2018–2025): the role of pre-test clinical suspicion Abstract format and assignment number: Poster, POS0111 Date: Thursday, 4…
EULAR 2025 highlights… EULAR 2025 Highlights – Rare and Autoinflammatory diseases 18 Jul 202518 Jul 2025 A WINDOW OF OPPORTUNITY IN STILL’S DISEASE: THE EARLY INTRODUCTION OF IL-1 INHIBITORS FOR ACHIEVING CLINICAL INACTIVE DISEASE Abstract format and assignment number: Poster 0377 Presenting author: S. Bindoli (Italy)…
ACR Highlights… ACR Convergence 2024 Highlights – Rare and Autoinflammatory diseases 19 Dec 202419 Dec 2024 Damage associated with disease-specific events and diagnostic or therapeutic procedures is highly prevalent in IgG4-related disease Abstract format and assignment number: Poster 0286 Presenting author: J. Stone (US) Date: Saturday,…
EULAR 2024 Highlights… EULAR 2024 Highlights – Rare and Autoinflammatory diseases 21 Jul 202421 Jul 2024 Author: Francesca Crisafulli Jachiet et al. (OP0231) evaluated retrospectively the efficacy and safety of azacitidine (AZA) treatment in 57 VEXAS patients, including 50 with myelodysplastic syndrome (MDS) and 7 without, from the French national…